Clinical trial
The Adult Antiretroviral Treatment and Resistance Study (Tshepo)
NCT00197613 · Harvard School of Public Health (HSPH), Other · Completed
Key facts
| NCT number | NCT00197613 |
|---|---|
| Title | The Adult Antiretroviral Treatment and Resistance Study (Tshepo) |
| Official title | The Adult Antiretroviral Treatment and Resistance Study (Tshepo) |
| Lead sponsor | Harvard School of Public Health (HSPH), Other |
| Collaborators | Princess Marina Hospital, Botswana Botswana Ministry of Health McGill University Health Centre/Research Institute of the McGill University Health Centre Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | AIDS, HIV Infection |
| Intervention type | Drug, Procedure |
| Interventions | (A) zidovudine, lamivudine and nevirapine, (B) zidovudine, lamivudine and efavirenz, (C) zidovudine, didanosine, and nevirapine, (D) zidovudine, and efavirenz, (E) stavudine and 4 more |
| Enrollment | 650 |
| Start date | Dec 1, 2002 |
| Completion | Dec 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 17, 2012 |
| Countries | Botswana |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: